Sugen, Inc. (extinct)

Sugen, Inc. (extinct)

Sugen, Inc. (extinct)

Overview
Date Founded

1991

Headquarters

230 E Grand Ave,San Francisco, CA 94080

Type of Company

Private

Industries

Pharmaceuticals
Medical Products & Equipment

Company Description

SUGEN (Sugen) was a drug discovery company focused on development of protein kinase inhibitors. It was founded in 1991, and shut down in 2003, after pioneering protein kinases as therapeutic targets and developing the successful cancer therapy sunitinib (Sutent).

Executives & Employees

Co-Founder

General Accounting Manager

Professional

Paths to Sugen, Inc.
Potential Connections via
Relationship Science
You
Sugen, Inc.
Recent Transactions
Details Hidden

Pharmacia & Upjohn, Inc. purchases Sugen, Inc.

Details Hidden

Zeneca Group Plc purchases Sugen, Inc.

Transaction Advisors
Legal Advisor

Advised onPharmacia & Upjohn, Inc. purchases Sugen, Inc.

Accountant

Advised onPharmacia & Upjohn, Inc. purchases Sugen, Inc.

Investment Advisor

Advised onPharmacia & Upjohn, Inc. purchases Sugen, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sugen, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sugen, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Sugen, Inc..